Myriad Genetics beat estimated earnings by 180.0%, reporting an EPS of $0.04 versus an estimate of $-0.05. Revenue was down $800 thousand from the same period last year. In the previous quarter, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results